Neus Ruiz-Xivillé , Mireia Morgades , Laura Blanco , Dolors Costa , Blanca Espinet , Elisabet Talavera , Emma Triviño , Margarita Ortega , Eva Villamon , Lurdes Zamora , José Tomás Navarro , Montserrat Arnan , Susana Vives , Jordi Esteve , Jorge Sierra , Josep-Maria Ribera , Isabel Granada
{"title":"采用风险调整方案治疗的新诊断急性髓系白血病细胞遗传改变的预后影响","authors":"Neus Ruiz-Xivillé , Mireia Morgades , Laura Blanco , Dolors Costa , Blanca Espinet , Elisabet Talavera , Emma Triviño , Margarita Ortega , Eva Villamon , Lurdes Zamora , José Tomás Navarro , Montserrat Arnan , Susana Vives , Jordi Esteve , Jorge Sierra , Josep-Maria Ribera , Isabel Granada","doi":"10.1016/j.medcli.2025.107106","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and objective</h3><div>In acute myeloid leukemia (AML), cytogenetic alterations have influence on treatment response and are essential for risk stratification, although some have uncertain prognostic relevance. In this study, the prognostic impact of cytogenetic alterations was analyzed in a series of newly diagnosed AML patients treated with risk-adapted protocols.</div></div><div><h3>Patients and method</h3><div>The cytogenetic profile of 1417 adult patients diagnosed with de novo AML (without t(15;17) or <em>PML</em>::<em>RARA</em>) enrolled in the CETLAM cooperative group protocols from 1994 to 2012 was studied, and its impact on survival was evaluated.</div></div><div><h3>Results</h3><div>Multivariable analysis showed that anomalies such as t(8;21) and inv(16)/t(16;16) predict a favorable prognosis, with no significant effect of additional anomalies on outcome. In contrast, abnormalities like monosomy of chromosome<!--> <!-->7, structural alterations of chromosome<!--> <!-->1, complex karyotype (5 or more abnormalities), and monosomal karyotype were associated with worse outcomes. Patients were classified into three prognostic groups based on their cytogenetic alterations, which demonstrated the effectiveness of the proposed system in predicting prognosis.</div></div><div><h3>Conclusion</h3><div>This study confirms the prognostic impact of cytogenetic alterations in AML and their usefulness in stratifying patients into risk groups.</div></div>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 4","pages":"Article 107106"},"PeriodicalIF":2.1000,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impacto pronóstico de las alteraciones citogenéticas en la leucemia aguda mieloide de nuevo diagnóstico tratada con protocolos adaptados al riesgo\",\"authors\":\"Neus Ruiz-Xivillé , Mireia Morgades , Laura Blanco , Dolors Costa , Blanca Espinet , Elisabet Talavera , Emma Triviño , Margarita Ortega , Eva Villamon , Lurdes Zamora , José Tomás Navarro , Montserrat Arnan , Susana Vives , Jordi Esteve , Jorge Sierra , Josep-Maria Ribera , Isabel Granada\",\"doi\":\"10.1016/j.medcli.2025.107106\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and objective</h3><div>In acute myeloid leukemia (AML), cytogenetic alterations have influence on treatment response and are essential for risk stratification, although some have uncertain prognostic relevance. In this study, the prognostic impact of cytogenetic alterations was analyzed in a series of newly diagnosed AML patients treated with risk-adapted protocols.</div></div><div><h3>Patients and method</h3><div>The cytogenetic profile of 1417 adult patients diagnosed with de novo AML (without t(15;17) or <em>PML</em>::<em>RARA</em>) enrolled in the CETLAM cooperative group protocols from 1994 to 2012 was studied, and its impact on survival was evaluated.</div></div><div><h3>Results</h3><div>Multivariable analysis showed that anomalies such as t(8;21) and inv(16)/t(16;16) predict a favorable prognosis, with no significant effect of additional anomalies on outcome. In contrast, abnormalities like monosomy of chromosome<!--> <!-->7, structural alterations of chromosome<!--> <!-->1, complex karyotype (5 or more abnormalities), and monosomal karyotype were associated with worse outcomes. Patients were classified into three prognostic groups based on their cytogenetic alterations, which demonstrated the effectiveness of the proposed system in predicting prognosis.</div></div><div><h3>Conclusion</h3><div>This study confirms the prognostic impact of cytogenetic alterations in AML and their usefulness in stratifying patients into risk groups.</div></div>\",\"PeriodicalId\":18578,\"journal\":{\"name\":\"Medicina Clinica\",\"volume\":\"165 4\",\"pages\":\"Article 107106\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-07-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicina Clinica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0025775325003343\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Clinica","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0025775325003343","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Impacto pronóstico de las alteraciones citogenéticas en la leucemia aguda mieloide de nuevo diagnóstico tratada con protocolos adaptados al riesgo
Background and objective
In acute myeloid leukemia (AML), cytogenetic alterations have influence on treatment response and are essential for risk stratification, although some have uncertain prognostic relevance. In this study, the prognostic impact of cytogenetic alterations was analyzed in a series of newly diagnosed AML patients treated with risk-adapted protocols.
Patients and method
The cytogenetic profile of 1417 adult patients diagnosed with de novo AML (without t(15;17) or PML::RARA) enrolled in the CETLAM cooperative group protocols from 1994 to 2012 was studied, and its impact on survival was evaluated.
Results
Multivariable analysis showed that anomalies such as t(8;21) and inv(16)/t(16;16) predict a favorable prognosis, with no significant effect of additional anomalies on outcome. In contrast, abnormalities like monosomy of chromosome 7, structural alterations of chromosome 1, complex karyotype (5 or more abnormalities), and monosomal karyotype were associated with worse outcomes. Patients were classified into three prognostic groups based on their cytogenetic alterations, which demonstrated the effectiveness of the proposed system in predicting prognosis.
Conclusion
This study confirms the prognostic impact of cytogenetic alterations in AML and their usefulness in stratifying patients into risk groups.
期刊介绍:
Medicina Clínica, fundada en 1943, es una publicación quincenal dedicada a la promoción de la investigación y de la práctica clínica entre los especialistas de la medicina interna, así como otras especialidades. Son características fundamentales de esta publicación el rigor científico y metodológico de sus artículos, la actualidad de los temas y, sobre todo, su sentido práctico, buscando siempre que la información sea de la mayor utilidad en la práctica clínica.